This trial is testing whether melatonin can decrease the incidence of postoperative delirium in elderly patients.
- Noncardiac Surgery
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Find a site
Who is running the clinical trial?
Frequently Asked Questions
What are the main goals of this experiment?
"The primary endpoint of this medical trial, which will span approximately 3 months, is to monitor the rate of recruitment. Secondary objectives include assessing the severity of delirium using the Confusion Assessment Method (CAM) severity form, measuring ICU care requirements during hospitalization and recording presence or absence of delirium through utilization of either CAM-short form or CAM-ICU tool depending on whether a patient is mechanically ventilated."
What is the current enrollment for this clinical trial?
"Affirmative. The clinicaltrial.gov website states that this trial is currently enrolling patients, with the initial listing posted on September 14th 2021 and last updated October 1st 2021. In total, 120 participants are being sought from two different study sites."
Are there any new opportunities to partake in this research?
"According to the clinicaltrials.gov database, this clinical trial is presently engaging in participant recruitment efforts; the initial post was made on September 14th of 2021 and a subsequent update was issued one month later."